Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials.

Sung-Eun Kim, Hee Young Paik, Hyuk Yoon, Jung Eun Lee, Nayoung Kim, Mi-Kyung Sung, Sex- and gender-specific disparities in colorectal cancer risk World Journal of Gastroenterology. ,vol. 21, pp. 5167- 5175 ,(2015) , 10.3748/WJG.V21.I17.5167

Yan Zhang, Junli Ma, Sai Zhang, Ganlu Deng, Xiaoling Wu, Jingxuan He, Haiping Pei, Hong Shen, Shan Zeng, A prognostic analysis of 895 cases of stage III colon cancer in different colon subsites. International Journal of Colorectal Disease. ,vol. 30, pp. 1173- 1183 ,(2015) , 10.1007/S00384-015-2273-Z

Enric Domingo, Rajarajan Ramamoorthy, Dahmane Oukrif, Daniel Rosmarin, Michal Presz, Haitao Wang, Hannah Pulker, Helen Lockstone, Tarjei Hveem, Treena Cranston, Havard Danielsen, Marco Novelli, Brian Davidson, Zheng‐Zhou Xu, Peter Molloy, Elaine Johnstone, Christopher Holmes, Rachel Midgley, David Kerr, Oliver Sieber, Ian Tomlinson, Use of multivariate analysis to suggest a new molecular classification of colorectal cancer. The Journal of Pathology. ,vol. 229, pp. 441- 448 ,(2013) , 10.1002/PATH.4139

S.Y. Brulé, D.J. Jonker, C.S. Karapetis, C.J. O’Callaghan, M.J. Moore, R. Wong, N.C. Tebbutt, Cr. Underhill, D. Yip, J.R. Zalcberg, D. Tu, R.A. Goodwin, Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17 European Journal of Cancer. ,vol. 51, pp. 1405- 1414 ,(2015) , 10.1016/J.EJCA.2015.03.015

Per Jess, Iben Onsberg Hansen, Possible better long-term survival in left versus right-sided colon cancer - a systematic review. Danish Medical Journal. ,vol. 59, ,(2012)

Volker Heinemann, Sebastian Stintzing, Dominik P. Modest, Clemens Giessen-Jung, Marlies Michl, Ulrich R. Mansmann, Early tumour shrinkage (ETS) and depth of response (DpR) in the treatment of patients with metastatic colorectal cancer (mCRC) European Journal of Cancer. ,vol. 51, pp. 1927- 1936 ,(2015) , 10.1016/J.EJCA.2015.06.116

Justin Guinney, Rodrigo Dienstmann, Xin Wang, Aurélien De Reynies, Andreas Schlicker, Charlotte Soneson, Laetitia Marisa, Paul Roepman, Gift Nyamundanda, Paolo Angelino, Brian M Bot, Jeffrey S Morris, Iris M Simon, Sarah Gerster, Evelyn Fessler, Felipe De Sousa E Melo, Edoardo Missiaglia, Hena Ramay, David Barras, Krisztian Homicsko, Dipen Maru, Ganiraju C Manyam, Bradley Broom, Valerie Boige, Beatriz Perez-Villamil, Ted Laderas, Ramon Salazar, Joe W Gray, Douglas Hanahan, Josep Tabernero, Rene Bernards, Stephen H Friend, Pierre Laurent-Puig, Jan Paul Medema, Anguraj Sadanandam, Lodewyk Wessels, Mauro Delorenzi, Scott Kopetz, Louis Vermeulen, Sabine Tejpar, None, The consensus molecular subtypes of colorectal cancer Nature Medicine. ,vol. 21, pp. 1350- 1356 ,(2015) , 10.1038/NM.3967

Christine M Dejea, Elizabeth C Wick, Elizabeth M Hechenbleikner, James R White, Jessica L Mark Welch, Blair J Rossetti, Scott N Peterson, Erik C Snesrud, Gary G Borisy, Mark Lazarev, Ellen Stein, Jamuna Vadivelu, April C Roslani, Ausuma A Malik, Jane W Wanyiri, Khean L Goh, Iyadorai Thevambiga, Kai Fu, Fengyi Wan, Nicolas Llosa, Franck Housseau, Katharine Romans, XinQun Wu, Florencia M McAllister, Shaoguang Wu, Bert Vogelstein, Kenneth W Kinzler, Drew M Pardoll, Cynthia L Sears, None, Microbiota organization is a distinct feature of proximal colorectal cancers Proceedings of the National Academy of Sciences of the United States of America. ,vol. 111, pp. 18321- 18326 ,(2014) , 10.1073/PNAS.1406199111

Barry Iacopetta, Are there two sides to colorectal cancer International Journal of Cancer. ,vol. 101, pp. 403- 408 ,(2002) , 10.1002/IJC.10635

Volker Heinemann, Ludwig Fischer von Weikersthal, Thomas Decker, Alexander Kiani, Ursula Vehling-Kaiser, Salah-Eddin Al-Batran, Tobias Heintges, Christian Lerchenmüller, Christoph Kahl, Gernot Seipelt, Frank Kullmann, Martina Stauch, Werner Scheithauer, Jörg Hielscher, Michael Scholz, Sebastian Müller, Hartmut Link, Norbert Niederle, Andreas Rost, Heinz-Gert Höffkes, Markus Moehler, Reinhard U Lindig, Dominik P Modest, Lisa Rossius, Thomas Kirchner, Andreas Jung, Sebastian Stintzing, FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial Lancet Oncology. ,vol. 15, pp. 1065- 1075 ,(2014) , 10.1016/S1470-2045(14)70330-4